Anti-ghrelin vaccine for obesity: A feasible alternative to dieting?

Expert Review of Vaccines

Volumn 10, Issue 10, 2011, Pages 1363-1365

  Monteiro, Mariana P ^a  

^a UNIVERSITY OF PORTO   (Portugal)

Author keywords

ghrelin; obesity; vaccine

Indexed keywords

ANTIOBESITY AGENT; GHRELIN; GHRELIN ANTIBODY; KEYHOLE LIMPET HEMOCYANIN; NEUROPEPTIDE Y; PROOPIOMELANOCORTIN; RECOMBINANT VACCINE; UNCLASSIFIED DRUG; VIRUS LIKE PARTICLE VACCINE;

B LYMPHOCYTE ACTIVATION; BARIATRIC SURGERY; COST EFFECTIVENESS ANALYSIS; DIET; ENERGY BALANCE; ENERGY EXPENDITURE; FOOD INTAKE; GLUCOSE TOLERANCE; HUMAN; METABOLIC RATE; NONHUMAN; OBESITY; PRIORITY JOURNAL; REVIEW; WEIGHT GAIN; WEIGHT REDUCTION;

DIET; ENERGY METABOLISM; FEASIBILITY STUDIES; GHRELIN; HOMEOSTASIS; HUMANS; OBESITY; VACCINES;

EID: 80053959169     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/erv.11.115     Document Type: Review

References (20)

1. Moayyedi P. The epidemiology of obesity and gastrointestinal and other diseases: an overview. Dig. Dis. Sci. 53(9), 2293-2299 (2008).
2. Snow V, Barry P, Fitterman N, Qaseem A, Weiss K. Pharmacologic and surgical management of obesity in primary care: a clinical practice guideline from the American College of Physicians. Ann. Intern. Med. 142(7), 525-531 (2005).
3. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402(6762), 656-660 (1999).
4. Cone RD, Cowley MA, Butler AA, Fan W, Marks DL, Low MJ. The arcuate nucleus as a conduit for diverse signals relevant to energy homeostasis. Int. J. Obes. Relat. Metab. Disord. 25(Suppl. 5), S63-S67 (2001).
5. Wren AM, Seal LJ, Cohen MA et al. Ghrelin enhances appetite and increases food intake in humans. J. Clin. Endocrinol. Metab. 86(12), 5992 (2001).
6. Dornonville De La Cour C, Lindqvist A, Egecioglu E et al. Ghrelin treatment reverses the reduction in weight gain and body fat in gastrectomised mice. Gut 54(7), 907-913 (2005).
7. Tschop M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature 407(6806), 908-913 (2000).
8. Wortley KE, Anderson KD, Garcia K et al. Genetic deletion of ghrelin does not decrease food intake but influences metabolic fuel preference. Proc. Natl Acad. Sci. USA 101(21), 8227-8232 (2004).
9. Cummings DE, Weigle DS, Frayo RS et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N. Engl. J. Med. 346(21), 1623-1630 (2002).
10. Monteiro MP, Ribeiro AH, Nunes AF et al. Increase in ghrelin levels after weight loss in obese Zucker rats is prevented by gastric banding. Obes. Surg. 17(12), 1599-1607 (2007).
11. Lu SC, Xu J, Chinookoswong N et al. An acyl-ghrelin-specific neutralizing antibody inhibits the acute ghrelin-mediated orexigenic effects in mice. Mol. Pharmacol. 75(4), 901-907 (2009).
12. Mayorov AV, Amara N, Chang JY et al. Catalytic antibody degradation of ghrelin increases whole-body metabolic rate and reduces refeeding in fasting mice. Proc. Natl Acad. Sci. USA 105(45), 17487-17492 (2008).
13. Esler WP, Rudolph J, Claus TH et al. Small-molecule ghrelin receptor antagonists improve glucose tolerance, suppress appetite, and promote weight loss. Endocrinology 148(11), 5175-5185 (2007).
14. Zorrilla EP, Iwasaki S, Moss JA et al. Vaccination against weight gain. Proc. Natl Acad. Sci. USA 103(35), 13226-13231 (2006).
15. Vizcarra JA, Kirby JD, Kim SK, Galyean ML. Active immunization against ghrelin decreases weight gain and alters plasma concentrations of growth hormone in growing pigs. Domest. Anim. Endocrinol. 33(2), 176-189 (2007).
16. Brown MJ. Therapeutic potential of vaccines in the management of hypertension. Drugs 68(18), 2557-2560 (2008).
17. Lechner F, Jegerlehner A, Tissot AC et al. Virus-like particles as a modular system for novel vaccines. Intervirology 45(4-6), 212-217 (2002).
18. + Th cell and protective humoral responses. Virology 302(2), 383-392 (2002).
19. Andrade S, Carreira M, Ribeiro A. Development of an anti-gherelin vaccine for obesity treatment. Endocr. Rev. 32(03) (2011).
20. Goldstone AP, Thomas EL, Brynes AE et al. Elevated fasting plasma ghrelin in Prader-Willi syndrome adults is not solely explained by their reduced visceral adiposity and insulin resistance. J. Clin. Endocrinol. Metab. 89(4), 1718-1726 (2004).